Page last updated: 2024-11-08

mycosamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

mycosamine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID182095
CHEBI ID32570
SCHEMBL ID788393
MeSH IDM0063429

Synonyms (22)

Synonym
mycosamine
CHEBI:32570
527-38-8
mycosamin
3-amino-3-desoxy-d-rhamnose
3-amino-3,6-dideoxy-d-mannose
(2s,3s,4s,5r)-3-amino-2,4,5-trihydroxyhexanal
d-mannose, 3-amino-3,6-dideoxy-
unii-1khw2634r4
32817-12-2
1khw2634r4 ,
SCHEMBL788393
mannose, 3-amino-3,6-dideoxy-, d-
3,6-dideoxy-3-amino-d-mannopyranose
3-amino-3,6-dideoxy-d-aldohexose
mycosamine [mi]
Q27114995
3-amino-3,6-dideoxyhexose
DTXSID00954473
A902078
3-amino-3,6-dideoxymannose;b,hcl-d-3-amino-3,6-dideoxymannose;d-3-amino-3,6-dideoxymannose
E80521
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
mannosamine
deoxymannose derivativeA deoxyhexose derivative that is formally obtained from deoxymannose.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's2 (13.33)18.2507
2000's6 (40.00)29.6817
2010's5 (33.33)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.45 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.93 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]